Efficacy of a novel patient-focused intervention aimed at increasing adherence to guideline-based preventive measures in asplenic patients: the PrePSS trial.
Asplenia
Health action process approach
Post-splenectomy sepsis
Vaccination
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
05
05
2023
accepted:
17
08
2023
medline:
27
11
2023
pubmed:
1
9
2023
entrez:
31
8
2023
Statut:
ppublish
Résumé
To determine whether a novel intervention improves the adherence to guideline-based preventive measures in asplenic patients at risk of post-splenectomy sepsis (PSS). We used a prospective controlled, two-armed historical control group design to compare a novel, health action process approach (HAPA)-based telephonic intervention involving both patients and their general practitioners to usual care. Eligible patients were identified in cooperation with the insurance provider AOK Baden-Wuerttemberg, Germany. Patients with anatomic asplenia (n = 106) were prospectively enrolled and compared to a historical control group (n = 113). Comparisons were done using a propensity-score-based overlap-weighting model. Adherence to preventive measures was quantified by the study-specific 'Preventing PSS score' (PrePSS score) which includes pneumococcal and meningococcal vaccination status, the availability of a stand-by antibiotic and a medical alert card. At six months after the intervention, we estimated an effect of 3.96 (95% CI 3.68-4.24) points on the PrePSS score scale (range 0-10) with mean PrePSS scores of 3.73 and 7.70 in control and intervention group, respectively. Substantial improvement was seen in all subcategories of the PrePSS score with the highest absolute gains in the availability of stand-by antibiotics. We graded the degree of participation by the general practitioner (no contact, short contact, full intervention) and noted that the observed effect was only marginally influenced by the degree of physician participation. Patients who had received the intervention exhibited a significantly higher adherence to guideline-based preventive measures compared to the control group. These data suggest that widespread adoption of this pragmatic intervention may improve management of asplenic patients. Health insurance provider-initiated identification of at-risk patients combined with a patient-focused intervention may serve as a blueprint for a wide range of other preventive efforts leading to patient empowerment and ultimately to better adherence to standards of care.
Identifiants
pubmed: 37653288
doi: 10.1007/s15010-023-02088-7
pii: 10.1007/s15010-023-02088-7
pmc: PMC10665246
doi:
Substances chimiques
Anti-Bacterial Agents
0
Types de publication
Controlled Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1787-1795Subventions
Organisme : Innovationsausschuss of the Gemeinsamer Bundesausschuss
ID : 01VSF17049
Informations de copyright
© 2023. The Author(s).
Références
Open Forum Infect Dis. 2015 Nov 03;2(4):ofv165
pubmed: 26668815
Rehabil Psychol. 2011 Aug;56(3):171-81
pubmed: 21767037
Cureus. 2020 Feb 6;12(2):e6898
pubmed: 32195065
Ann Behav Med. 2007 Apr;33(2):156-66
pubmed: 17447868
BMC Public Health. 2018 Nov 6;18(1):1230
pubmed: 30400790
Hematol J. 2004;5(1):77-80
pubmed: 14745434
Open Forum Infect Dis. 2020 Feb 13;7(3):ofaa050
pubmed: 32158777
Vaccine. 2008 Dec 9;26(52):6975-9
pubmed: 18848594
Expert Rev Vaccines. 2021 Mar;20(3):297-308
pubmed: 33538617
Am J Med. 2017 Jul;130(7):856-861
pubmed: 28213046
Intern Emerg Med. 2017 Dec;12(8):1139-1147
pubmed: 28799083
PLoS One. 2011 Mar 10;6(3):e17302
pubmed: 21423748
Infect Drug Resist. 2019 Sep 12;12:2839-2851
pubmed: 31571940
Lancet. 2011 Jul 2;378(9785):86-97
pubmed: 21474172
Health Psychol. 2011 Jul;30(4):492-500
pubmed: 21534678
J Surg Res. 2015 Dec;199(2):580-5
pubmed: 26163332
J Infect Public Health. 2017 Nov - Dec;10(6):803-808
pubmed: 28189514
Dtsch Med Wochenschr. 2009 Apr;134 Suppl 2:S65-70
pubmed: 19353474
Clin Infect Dis. 2016 Apr 1;62(7):871-878
pubmed: 26703862
Biometrics. 2021 Sep;77(3):1101-1117
pubmed: 32662087
Br J Haematol. 2011 Nov;155(3):308-17
pubmed: 21988145
Am J Epidemiol. 2019 Jan 1;188(1):250-257
pubmed: 30189042
BMC Infect Dis. 2020 Jan 14;20(1):41
pubmed: 31937251
Hum Vaccin Immunother. 2016 May 3;12(5):1277-9
pubmed: 26890256
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 May;63(5):588-644
pubmed: 32350583
Med J Aust. 2014 May 19;200(9):538-40
pubmed: 24835718
Psychol Health. 2012;27(7):829-45
pubmed: 21867395
Circulation. 2018 Jul 10;138(2):e48-e74
pubmed: 29866648
Rev Med Interne. 2017 Jul;38(7):436-443
pubmed: 28190612
Psychol Health. 2013;28(5):579-92
pubmed: 23259583